0000950170-24-026682.txt : 20240305
0000950170-24-026682.hdr.sgml : 20240305
20240305202843
ACCESSION NUMBER: 0000950170-24-026682
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240304
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Heino Mary Anne
CENTRAL INDEX KEY: 0001610676
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36569
FILM NUMBER: 24723940
MAIL ADDRESS:
STREET 1: C/O LANTHEUS HOLDINGS, INC.
STREET 2: 331 TREBLE COVE ROAD
CITY: NORTH BILLERICA
STATE: NY
ZIP: 01862
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lantheus Holdings, Inc.
CENTRAL INDEX KEY: 0001521036
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 352318913
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 331 TREBLE COVE ROAD
CITY: NORTH BILLERICA
STATE: MA
ZIP: 01862
BUSINESS PHONE: 978 671-8001
MAIL ADDRESS:
STREET 1: 331 TREBLE COVE ROAD
CITY: NORTH BILLERICA
STATE: MA
ZIP: 01862
FORMER COMPANY:
FORMER CONFORMED NAME: Lantheus MI Holdings, Inc.
DATE OF NAME CHANGE: 20110517
4
1
ownership.xml
4
X0508
4
2024-03-04
0001521036
Lantheus Holdings, Inc.
LNTH
0001610676
Heino Mary Anne
C/O LANTHEUS HOLDINGS, INC.
201 BURLINGTON ROAD, SOUTH BLDG
BEDFORD
MA
01730
true
false
false
false
true
Common Stock
2024-03-04
4
A
false
81169
0.00
A
345506
D
Common Stock
2024-03-04
4
S
false
34512
64.8108
D
310994
D
Common Stock
2024-03-04
4
S
false
59251
65.5941
D
251743
D
Common Stock
2024-03-04
4
S
false
100
66.225
D
251643
D
Common Stock
78980
I
By Grantor Retained Annuity Trust
Common Stock
300000
I
By Grantor Retained Annuity Trust
The transaction reported in this Form 4 reflects additional shares of common stock issued by Lantheus Holdings, Inc. ("LNTH") to the reporting person upon the vesting of relative Total Shareholder Return PSUs that were previously granted and included in the Form 4 filed on March 8, 2021. The number of shares reported in the Form 4 reflected 100% of the target number of shares underlying the PSUs. The number of shares that actually vested under the PSUs equaled 200% of the target number of shares. Accordingly, the number of shares reported in this Form 4 reflects the difference between the number of shares that actually vested under the PSUs and the target number of shares originally included in the Form 4.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.14 to $65.13, inclusive. The reporting person undertakes to provide to LNTH any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.14 to $66.10, inclusive. The reporting person undertakes to provide to LNTH any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
/s/ Eric M. Green, attorney-in-fact
2024-03-05